Jupiter Research Capital (Asia) Ltd’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Buy
13,407
+2,454
+22% +$47K 0.03% 549
2026
Q2
$205K Sell
10,953
-3,617
-25% -$52.5K 0.02% 633
2026
Q1
$145K Buy
14,570
+4,534
+45% +$40.6K 0.02% 678
2025
Q4
$84.9K Buy
+10,036
New +$71.6K 0.02% 553

Other funds holding RLAY

Jupiter Research Capital (Asia) Ltd's RLAY Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd increased its Relay Therapeutics (RLAY) stake by 22% in Q3 2026, buying an estimated $47K and bringing the position to 13,407 shares worth $242K. The position accounts for 0.03% of the portfolio, ranked #549.

Jupiter Research Capital (Asia) Ltd first reported a position in RLAY in Q4 2025 and has held it in 4 quarters since. 250 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 13,407 shares of Relay Therapeutics worth $242K as of Q3 2026.
  • Jupiter Research Capital (Asia) Ltd bought 2,454 Relay Therapeutics shares in Q3 2026, an estimated $47K.
  • Relay Therapeutics made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #549 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Relay Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 250 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.